Latest news with #SeriesA
Yahoo
2 days ago
- Business
- Yahoo
Zacks Initiates Coverage of Medalist Diversified REIT With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Medalist Diversified REIT, Inc. MDRR, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed outlook for the company, which has been making notable strides in the real estate investment trust (REIT) space despite industry challenges. MDRR, headquartered in Richmond, VA, is a REIT specializing in acquiring, repositioning, renovating, leasing and managing income-producing properties. Its portfolio centers on two primary areas — legacy retail and flex-industrial assets in secondary and tertiary markets within Virginia, North Carolina and South Carolina, and a growing portfolio of single-tenant net lease (STNL) properties located across the United States. In the first quarter of 2025, Medalist Diversified REIT delivered several encouraging developments despite a tough operating environment. Revenues from its STNL segment surged 156.5% year over year, reflecting the company's strategic shift toward stable, long-term leased assets. This expansion was driven by the successful acquisitions of Buffalo Wild Wings and United Rentals properties, which strengthened recurring income and improved cash flow visibility. The research report highlights several key factors that could drive MDRR's future growth. These include its successful transition to fully leased STNL properties, which offer predictable, long-term rental income and reduced exposure to tenant turnover. Medalist Diversified REIT's recent redemption of its 8% Series A preferred stock has significantly lowered financing costs and improved net income prospects. Additionally, the company benefits from a mostly fixed-rate debt profile, offering insulation from interest rate spikes and ensuring more predictable debt servicing. However, potential investors should consider certain risks outlined in the report. Medalist Diversified REIT continues to report net losses and operating expenses that outpace revenues, raising concerns about scale and efficiency. The small property base, just 12 developed assets, makes MDRR vulnerable to tenant attrition and limits diversification. Moreover, governance concerns linger due to related-party transactions, including two STNL acquisitions from entities controlled by the REIT's CEO. Although approved under MDRR's policies, such deals may deter institutional interest. Medalist Diversified REIT stock has significantly underperformed its industry peers and the broader market over the past year. The valuation metrics for the company indicate investor caution about the company's asset base but also some optimism about its earnings potential. MDRR's stock trades at a discount to peers on asset value metrics, reflecting concerns about property quality, scale and financial leverage. However, it commands a premium on earnings-based multiples, suggesting investors are pricing in expectations of improved operational performance following recent strategic and financial changes. For a comprehensive analysis of Medalist Diversified REIT's financial health, strategic initiatives, and market positioning, you are encouraged to view the full Zacks research report. This in-depth report provides a detailed discussion of the company's operational strategies, financial performance, and the potential risks and opportunities that lie ahead. Read the full Research Report on Medalist Diversified REIT here>>> Note: Our initiation of coverage on Medalist Diversified REIT, which has a modest market capitalization of $15.9 million, aims to equip investors with the information needed to make informed decisions in this promising but inherently risky segment of the market. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medalist Diversified REIT, Inc. (MDRR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025
Dallas, Texas--(Newsfile Corp. - May 28, 2025) - Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). During the third quarter of fiscal year 2025, IXHL reported R&D expenses of $2.74M, down from $3.28M in the same quarter of the previous year, reflecting cost containment measures. SG&A expenses were $2.27M, compared to $4.14M in the prior year, driven by strategic cost-saving initiatives. The net loss for the quarter was reduced to $3.97M from $6.03M year-over-year, partly supported by improved operational efficiencies. Cash and cash equivalents totaled $6.7M, an increase from $2.1M as of 2Q24 end, due to recent financing activities and received R&D tax incentive payments. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: IXHL will issue a total of ~$24.7M worth of shares to repurchase all outstanding Series A Warrants representing 347.2M shares that could be dilutive, highlighting management's proactive approach to capital management. Secured $12.5 million USD in private placement funding, priced at-the-market. When we use a probability adjusted DCF model, it returns an estimated share valuation range of $5.30 to $5.94 with a midpoint of $5.61. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@ Source: Stonegate, Inc. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
DLA Piper appoints Matt Tweedie as CFO
UK law firm DLA Piper has appointed Matt Tweedie as its new CFO, effective 1 July 2025. Tweedie, who will be based in London, joins from Knight Frank, where he served as group CFO and head of business services. 'He brings valuable experience to support the firm's growth strategy,' DLA Piper said. Tweedie joined Knight Frank, real estate consultancy, in 2018 and was promoted to group CFO and head of business services in 2019. Prior to his tenure at Knight Frank, he spent two decades at Arup, including 13 years as group CFO. DLA Piper international managing partner and global co-CEO Charles Severs said: 'Matt is a highly accomplished financial leader who will help us drive efficiency and achieve our strategic growth plans. His extensive experience makes him the ideal candidate to lead our finance function.' Tweedie added: "DLA Piper is a leading brand in the legal sector. Its strong client base, sector expertise, global reach and culture make the firm stand out. I look forward to working with Charles and the leadership team to contribute to the firm's continued success.' DLA Piper has offices across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The firm is involved in various advisory services, including recent engagements with multiple organisations. Among its recent advisory roles, DLA Piper advised on the warranty and indemnity (W&I) insurance for a 'leading' insurer. This was in connection with the acquisition of a majority interest in the JET fuel stations network in Germany and Austria by a consortium of Stonepeak and Energy Equation Partners. Additionally, DLA Piper advised Benchmark Holdings on its proposal to return capital to shareholders, the cancellation of the admission to trading of its ordinary shares on the LSE's AIM market and Euronext Growth Oslo, and its subsequent registration as a private limited company. In another development, DLA Piper advised Rhino Federated Computing in closing its $15m Series A financing round. "DLA Piper appoints Matt Tweedie as CFO " was originally created and published by International Accounting Bulletin, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
5 days ago
- Business
- Yahoo
Digital Twins in Healthcare Market Research and Forecast Report 2025-2030: Europe Emerges as Key Player in Digital Twin Healthcare Market, Second to North America
The global digital twin healthcare market is set for remarkable growth, projected to soar from USD 4.47 billion in 2025 to USD 59.94 billion by 2030, at a CAGR of 68.0%. The surge is fueled by the expanding applications of digital twins in healthcare and increased investments from public and private sectors. Quibim, a Valencia-based pioneer using imaging biomarkers for precision medicine, recently raised USD 50.6 million in Series A funding to expand into the U.S. Market leaders like Microsoft, Siemens Healthineers, and GE Healthcare are advancing the sector. Notably, surgical planning & medical education, driven by virtual reality integration, captures the largest market share. Europe emerges as a key region, with substantial technological investments. The report offers a detailed analysis of market trends, competitive dynamics, and opportunities for growth in digital twin technology. Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Digital Twins in Healthcare Market by Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2030" has been added to offering. The global digital twin healthcare market is poised for remarkable growth in 2024, driven by the expanding applications of digital twins and substantial investments from both public and private sectors. The market is expected to surge to USD 59.94 billion by 2030 from USD 4.47 billion in 2025, reflecting a CAGR of 68.0% during this period. Public and private sectors are keenly investing in digital twin technologies, recognizing their potential to revolutionize innovation and boost operational efficiency. Valencia-based Quibim is a leader in leveraging imaging biomarkers for precision medicine. Recently, Quibim secured USD 50.6 million in a Series A funding round aimed at establishing a foothold in the United States. This strategic move is seen as pivotal in advancing human digital twins, dynamic models that aid health monitoring, enhance patient stratification, increase drug development success rates, and enable pre-implementation treatment testing. By application, the surgical planning & medical education segment claimed the largest market share in 2024. The dominance of this segment is attributed to the fusion of digital twins with virtual reality platforms, significantly enhancing surgical training for residents. This technology allows for simulations tailored to individual patients' unique anatomical and physiological attributes, offering trainees a realistic experience and performance tracking through intraoperative metrics. Several companies have developed medical anatomy and surgical procedure simulations to reduce cadaver dependence and promote interactive learning. By end user, the healthcare providers segment commanded the largest market share in 2024. This segment's growth is linked to its critical role in workflow management and surgical planning. Digital twins provide benefits such as accurate patient modeling, personalized treatment planning, and continuous monitoring, all of which improve clinical decision-making and patient outcomes. Europe secured the second-largest market share in 2024 by region. This is due to increased technological investments and the application of digital twins in research and genomics. The European Institute of Innovation & Technology (EIT) Health Germany reports that digital twins are being employed across European nations to enhance medication prescriptions. French firm ExactCure specializes in digital health, focusing on preventing adverse drug effects. DigiTwins utilizes advanced omics, sensing, computing, and communication technologies, enabling completely personalized and preventive medicine, heralding a significant paradigm shift in healthcare. This report provides insights on: Drivers such as burgeoning investments in developed and emerging technology adoption, rising demand for personalized medicine, and increased funding and investment in digital twin startups. Restraints include concerns over accuracy and privacy in digital twin systems and high implementation costs. Opportunities and challenges are also examined. Product/Service Development & Innovation: Detailed insights into upcoming technologies, R&D activities, and new product and service launches. Market Development: Comprehensive data on lucrative emerging markets by type, component, application, end user, and region. Market Diversification: Information about product portfolios, expanding geographic reach, recent developments, and investments. Competitive Assessment: Thorough analysis of market shares, growth strategies, product offerings, and capabilities of leading players. Market Dynamics Market Drivers Increasing Investments by Public and Private Entities Growing Applications of Digital Twins Technological Advancements Growing Funding and Investments in Digital Twin Startups Challenges Lack of Skilled Professionals Integration With Existing Systems and Outdated Digital Infrastructure Industry Trends Transformation in Clinical Trials Revolutionizing Medical Training and Diagnostics Improving Operational Efficiency in Hospitals Opportunities Increasing Focus on Cutting-Edge Real-Time Data Analytics Growing Importance of Digital Twins in Emerging Economies Case Studies Utilization of Digital Twin Technology For Surge Planning Decisions Provision of Hospital Guidance Using Digital Twins in Healthcare During COVID-19 Pandemic Optimization of Cardiovascular Solutions For Personalized Treatments Company Profiles Microsoft Corporation Siemens Healthineers Ag Koninklijke Philips N.V. Amazon Web Services, Inc. Dassault Systemes Ge Healthcare Oracle Corporation IBM Ptc Sap Atos Se Nvidia Corporation Ansys Inc. Faststream Technologies Rescale, Inc. Twin Health Verto Qbio Thoughtwire Sim and Cure Predictiv Nurea Inc. Virtonomy Gmbh Predisurge For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Axios
6 days ago
- Business
- Axios
Exclusive: Converge raises $22M for concrete sensor
Converge, a concrete sensor and AI startup, has closed $22 million in the second tranche of a Series A round, the company tells Axios. Why it matters: AI-related climate firms are still getting funding as VC investment in the sector cools. Zoom in: A sustainability-focused fund of Dutch bank ABN Amro led the round. Participating investors included Climate Investment, Move Energy, Pi Impact, J-Impact, and existing investors TO Ventures and Force Over Mass Capital. The company plans to use the round to sell more of its sensors and software to builders, as well as continue to develop its AI product, said Converge CEO Raphael Scheps. Scheps says the tech is being used across "thousands of job sites," and hyperscalers have expressed interest in it. How it works: Converge makes a sensor that contractors can embed in concrete pours, which can deliver data about performance, temperature and strength. The sensor data can determine when pours harden, and how concrete is performing under different conditions. The company also has an AI product that can determine what types of concrete mixes would be best for different projects. Converge can help building projects lower carbon emissions from concrete by 20% to 40%, says Scheps. Builders can use Converge's AI to select mixes with less concrete and also test out greener concrete products. Zoom out: The building materials industry is a tricky sector to decarbonize, as construction companies are naturally risk-averse and slow-moving.
